NanoVation Therapeutics

NanoVation Therapeutics provides technology that utilizes lipid nanoparticles to safely and efficiently deliver nucleic acids to tissues. With the advent of gene therapy, we are at a pivotal turning point in human history. In our lifetime, we will witness major diseases becoming treatable or curable due to this new therapeutic approach. At NanoVation TherapeuticsTM (NTx), we are making this future a reality by enabling the safe and effective delivery of genetic medicines to target tissues within the body. Our next-generation platform technology uses lipid nanoparticles to deliver nucleic acids to various tissues. NTx develops scalable nucleic acid lipid nanoparticle (LNP) formulations tailored to specific targets, payloads, and routes of administration.